MT-ND6 and steatosis: In particular, NASH patients are characterized by severely enhanced hepatic DNMT levels [74], whereby inducing a higher methylation pattern of specific genes, including the mitochondrially encoded NADH dehydrogenase 6 (MT-ND6) compared to those with simple steatosis [74].